TIAA Trust, National Association’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-123
Closed -$18.8K – 375
2026
Q1
$18.8K Sell
123
-8,318
-99% -$1.28M ﹤0.01% 351
2025
Q4
$1.16M Sell
8,441
-269
-3% -$35.2K ﹤0.01% 366
2025
Q3
$1.12M Buy
8,710
+428
+5% +$52.2K ﹤0.01% 365
2025
Q2
$1M Sell
8,282
-192
-2% -$21.6K ﹤0.01% 378
2025
Q1
$945K Buy
8,474
+599
+8% +$63.8K ﹤0.01% 374
2024
Q4
$766K Buy
7,875
+569
+8% +$60.7K ﹤0.01% 401
2024
Q3
$840K Buy
7,306
+305
+4% +$34.6K ﹤0.01% 392
2024
Q2
$745K Sell
7,001
-851
-11% -$85.4K ﹤0.01% 388
2024
Q1
$760K Buy
7,852
+1,666
+27% +$171K ﹤0.01% 385
2023
Q4
$625K Sell
6,186
-928
-13% -$89.6K ﹤0.01% 396
2023
Q3
$725K Buy
+7,114
New +$722K ﹤0.01% 372

Other funds holding NVS

TIAA Trust, National Association's NVS Position: Q2 2026 in Review

TIAA Trust, National Association sold out of Novartis (NVS) in Q2 2026, closing a stake of 123 shares — an estimated $18.8K sold.

TIAA Trust, National Association first reported a position in NVS in Q3 2023 and held it in 11 quarters. The position peaked at $1.16M in Q4 2025. 1,625 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • TIAA Trust, National Association reported no remaining Novartis position as of Q2 2026 after selling out during the quarter.
  • TIAA Trust, National Association sold 123 Novartis shares in Q2 2026, an estimated $18.8K.
  • TIAA Trust, National Association first reported a position in Novartis in Q3 2023 and held it in 11 quarters.
  • TIAA Trust, National Association's Novartis position peaked at $1.16M in Q4 2025.
  • 1,625 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on TIAA Trust, National Association's 13F filing for Q2 2026, filed 10 Aug 2026.